PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16741367-3	2006	OBJECTIVE: In this study the capacity of desloratadine and loratadine to counteract human keratinocyte activation by interferon-gamma (IFN-gamma) was analyzed.	desloratadine	41-54	interferon gamma	Homo sapiens	117-133	
16741367-7	2006	RESULTS: Desloratadine and loratadine inhibited the constitutive and IFN-gamma-induced release of CCL5, CXCL8 and CXCL10 from keratinocytes, while the low release of CCL17 remained unchanged.	desloratadine	9-22	interferon gamma	Homo sapiens	69-78	
16741367-9	2006	CONCLUSIONS: The results indicate that desloratadine has the capacity to block the IFN-gamma-induced activation of keratinocytes, and that it can thus exert important regulatory effects on cell-mediated immune responses in the skin.	desloratadine	39-52	interferon gamma	Homo sapiens	83-92	
16741367-3	2006	OBJECTIVE: In this study the capacity of desloratadine and loratadine to counteract human keratinocyte activation by interferon-gamma (IFN-gamma) was analyzed.	desloratadine	41-54	interferon gamma	Homo sapiens	135-144